The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Sanuwave Health Wins Patent Challenge

16-Jun-2011 | Source : | Visits : 8580

ALPHARETTA, GA - SANUWAVE Health Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, reported that the US Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE’s US Patent No. 6,080,119 following a third party’s ex parte reexamination request.

A press release by the company stated that this innovative device and method patent describes the Company’s invention of effective catalyst concentrations to produce optimal medical shock waves.

The USPTO confirmed that SANUWAVE was entitled to amend the patent claims to the full range of catalyst concentrations disclosed in the ‘119 patent as a continuing novel innovation in medical shock wave treatment.

"We are very pleased that the reexamination proceedings have been brought to a successful conclusion. We believe that the issuance of this reexamination certificate confirms SANUWAVE’s technological leadership in medical shock wave technology," said Christopher M. Cashman, president and CEO of SANUWAVE.

"This patent recognizes our technology as a novel innovation, allowing us to aggressively defend our intellectual property. The strength of this intellectual property, combined with compelling clinical outcomes and favorable market dynamics, allow us to continually advance our PACE® technology across multiple market verticals, with a near-term focus on wound healing and orthopedics.”

PACE, defined as Pulsed Acoustic Cellular Expression, delivers high-energy acoustic pressure waves to produce compressive and tensile stresses on cells and tissue structures to promote angiogenic and positive inflammatory responses, and quickly initiate the healing cascade. This results in revascularization and microcirculatory improvement, including the production of angiogenic growth factors, enhanced new blood vessel formation (angiogenesis), and the subsequent regeneration of tissue such as skin, musculoskeletal and vascular structures.

PACE treatment triggers the initiation of an accelerated inflammatory response that speeds wounds into proliferation phases of healing, and subsequently returns a chronic condition to an acute condition to help re-initiate the body’s own healing response.

SANUWAVE Health Inc. is an emerging regenerative medicine company focused on the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures.


Related Articles